Abbott Laboratories (ABT) Current Taxes (2009 - 2026)

Abbott Laboratories has disclosed Current Taxes across 18 years of filings, most recently posting $598.0 million for Q1 2026.

• Current Taxes for Q1 2026 came in at $598.0 million, up 23.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $598.0 million (up 23.3% YoY), and the FY2025 annual result was $569.0 million, down 4.21% from the prior year.
• Current Taxes came in at $598.0 million for Q1 2026 at Abbott Laboratories, up from $569.0 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $713.0 million in Q3 2024 to a low of $273.0 million in Q2 2023.
• The 5-year median for Current Taxes is $469.0 million (2025), against an average of $460.5 million.
• Across the five-year window, Current Taxes soared 124.21% in 2024 and sank 35.11% in 2025, its largest moves.
• Abbott Laboratories' Current Taxes stood at $343.0 million in 2022, then surged by 43.44% to $492.0 million in 2023, then gained by 20.73% to $594.0 million in 2024, then fell by 4.21% to $569.0 million in 2025, then increased by 5.1% to $598.0 million in 2026.
• The last three Current Taxes figures came in at $598.0 million (Q1 2026), $569.0 million (Q4 2025), and $469.0 million (Q3 2025), per Business Quant data.